Oragenics, Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on November 23, 2021. The report addresses the outcome of the Company's Annual Meeting of Shareholders held on November 22, 2021.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses solely on corporate governance events and does not contain financial statement data.
Material Changes and Events
- Quorum Failure: The Annual Meeting of Shareholders called on November 22, 2021, was adjourned because a sufficient number of shares were not present or represented by proxy to constitute a quorum.
- Rescheduled Meeting: The Annual Meeting has been reconvened for January 25, 2022, at 4:00 p.m. Eastern Time.
- Location Change: The reconvened meeting will be held at the offices of Shumaker, Loop, & Kendrick in Tampa, FL, rather than the Company's principal executive offices.
- Proposals: No changes have been made to the proposals to be voted on by shareholders.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or new risk factors. The primary contingency noted is the requirement for shareholders to attend or vote at the rescheduled meeting to ensure a quorum is achieved. Shareholders who have already voted do not need to take further action unless they wish to change their vote.
Key Facts for Investor Verification
- Verify the date and location of the rescheduled Annual Meeting: January 25, 2022, at 4:00 p.m. ET in Tampa, FL.
- Confirm the record date for the meeting remains October 1, 2021.
- Review the definitive proxy statement (Schedule 14A) filed on October 13, 2021, for details on the proposals to be voted on.
- Note that the press release regarding the adjournment is furnished as Exhibit 99.1 and is not deemed "filed" under Section 18 of the Exchange Act.